The tiny biotechnology company Antigenics Inc (NASDAQ:AGEN) said on Tuesday it has won approval to market its kidney cancer vaccine, Oncophage, in Russia, making it the only cancer vaccine available in the world.
The product was approved despite failing to win approval in the United States. It is the first time the Russian government has approved a foreign drug that was not first cleared in its country of origin, Antigenics said. Antigenics is also planning to file for approval of the vaccine in Europe by the end of the year.
- Via Reuters
Notablecalls: Phew! This is unbelievable! World's 1st cancer vaccine is approved. This is historic. I expect to see some buy interest in other cancer vaccine names, mainly Dendreon (NASDAQ:DNDN).